Eleni Gavriilaki, MD, PhD, received her medical degree from the Aristotle University of Thessaloniki in Thessaloniki, Greece, in 2010, where she then participated in a postgraduate program in medical research methodology. In 2014, Dr. Gavriilaki completed a residency in internal medicine at the General Hospital of Edessa in Thessaloniki, Greece, followed by a postdoctoral fellowship at the John Hopkins School of Medicine in Baltimore, MD. In 2016, Dr. Gavriilaki completed her PhD with the Aristotle University of Thessaloniki and went on to become a Hematology Fellow at the George Papanikolaou Hospital in Thessaloniki, Greece. Dr. Gavriilaki has served as a Hematologist at the George Papanikolaou Hospital since 2020. Dr. Gavriilaki’s research is primarily in the field of transplantation. She has published many studies investigating the treatment of transplant-associated thrombotic microangiopathy (TA-TMA), an endothelial damage syndrome that is increasingly found as a complication of autologous and allogeneic hematopoietic cell transplantation. Many of these investigations have explored the therapeutic potential of monoclonal antibodies.
Athanasios Tragiannidis, MD, PhD is Associate Professor of
Pediatrics-Pediatric Hematology Oncology of the 2nd Department of Pediatrics at
the Aristotle University of Thessaloniki, Greece. Dr. Tragiannidis qualified
from the Medical School of Triest, Italy in 1997. His postgraduate education
included residency training in Pediatrics and Pediatric Hematology-Oncology at
the AHEPA University Hospital in Thessaloniki, fellowships in Hematology in
Papanikolaou Hospital in Thessaloniki and in Pediatric Hematology-Oncology in
the Department of Pediatric Hematology-Oncology at the University Children’s
Hospital in Muenster, Germany. He received a scholarship of the German
Academic Exchange Service (DAAD) for research in the Department of Pediatric
Hematology Oncology in the Children’s University Hospital in Muenster,
Germany. His major research interests include hematological malignancies,
fungal infections in the immunocompromised host, vaccines and the design and
conduct of clinical research studies. He has over 97 publications in
Pubmed, has participated as principal investigator or sub-investigator in more
than 12 clinical trials and is a member of many national and
international medical societies and acts as a reviewer in more than 20
international peer reviewed journals. He participates in the Editorial Board
and as a Guest Editor in the Journal of Fungi and in the Editorial Board of
Cardiovascular and Hematology Agents in medicinal chemistry journal.
